THC to Commence Trading on the CSE

VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 28, 2015) - THC BioMed Intl Ltd. (CSE:THC)(FRANKFURT:TFHC) ("THC") is pleased to announce that its common shares will commence trading on the Canadian Stock Exchange ('CSE") under the symbol "THC" at market open on April 29, 2015.

THC has two Marihuana for Medical Purposes Regulations ("MMPR") Licensed Producer applications being evaluated by Health Canada, one application having been submitted by each of THC's two wholly-owned subsidiaries. THC BioMed Ltd. ("BioMed"), one of THC's two subsidiaries, is at an advanced stage of the Health Canada MMPR application process. Health Canada has completed its Pre-License Inspection of BioMed's facility in Kelowna B.C. While there can be no assurance that an MMPR License will be granted, pursuant to the information provided by Health Canada, THC is now at the seventh and final stage of Health Canada's MMPR application process: "Licensing." Please see www.hc-sc.gc.ca "Application Process Steps for becoming a Licensed Producer. "If BioMed's application is approved, the next step is expected to be the granting of an MMPR License by Health Canada to BioMed. If an MMPR License is granted, it may authorize BioMed to produce marijuana but not sell it to the public until it has graduated to "Fully Authorized Licensed Producer" status, which would allow BioMed to produce marijuana and sell it to eligible persons under the MMPR.

In addition to THC's intention to become an MMPR Licensed Producer, THC currently offers consulting services for aspiring MMPR Licensed Producers and MMPR Licensed Producers. THC offers its services to aspiring MMPR Licensed Producers to guide and advise them throughout the MMPR License application process and to MMPR Licensed Producers to assist them through the graduated licensing process from cultivation only to fully authorized Licensed Producers. THC will also offers analytical services once licensed, using its state of the art equipment to ensure product meets all quality control standards, and conduct research and development for MMPR Licensed Producers.